Blue Chip Partners’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$21.4M Buy
208,691
+2,287
+1% +$258K 1.54% 27
2025
Q4
$25.9M Buy
206,404
+4,528
+2% +$577K 1.88% 21
2025
Q3
$27M Buy
201,876
+7,147
+4% +$938K 2.02% 21
2025
Q2
$26.5M Buy
194,729
+3,706
+2% +$489K 2.16% 18
2025
Q1
$25.3M Buy
191,023
+11,549
+6% +$1.47M 2.19% 18
2024
Q4
$20.3M Buy
179,474
+1,400
+0.8% +$162K 1.75% 21
2024
Q3
$20.3M Buy
178,074
+5,379
+3% +$590K 1.76% 23
2024
Q2
$17.9M Buy
172,695
+10,821
+7% +$1.15M 1.66% 26
2024
Q1
$18.4M Buy
161,874
+16,450
+11% +$1.89M 1.79% 25
2023
Q4
$16M Sell
145,424
-6,636
-4% -$663K 1.67% 26
2023
Q3
$14.7M Buy
152,060
+3,205
+2% +$337K 1.76% 25
2023
Q2
$16.2M Buy
148,855
+4,931
+3% +$526K 1.84% 26
2023
Q1
$14.6M Buy
143,924
+8,012
+6% +$846K 1.73% 29
2022
Q4
$14.9M Buy
135,912
+27,309
+25% +$2.83M 1.86% 25
2022
Q3
$10.5M Buy
108,603
+417
+0.4% +$44.4K 1.44% 31
2022
Q2
$11.8M Buy
108,186
+5,480
+5% +$622K 1.5% 32
2022
Q1
$12.2M Buy
102,706
+10,514
+11% +$1.3M 1.51% 30
2021
Q4
$13M Buy
92,192
+10,165
+12% +$1.3M 1.63% 27
2021
Q3
$9.69M Buy
82,027
+50,822
+163% +$6.24M 1.36% 30
2021
Q2
$3.62M Buy
31,205
+17
+0.1% +$1.98K 0.52% 36
2021
Q1
$3.74M Sell
31,188
-607
-2% -$71.9K 0.57% 37
2020
Q4
$3.48M Buy
31,795
+310
+1% +$33.7K 0.55% 37
2020
Q3
$3.43M Buy
31,485
+58
+0.2% +$5.88K 0.61% 35
2020
Q2
$2.87M Sell
31,427
-12
-0% -$1.08K 0.56% 36
2020
Q1
$2.48M Sell
31,439
-4,793
-13% -$400K 0.62% 37
2019
Q4
$3.15M Sell
36,232
-132
-0.4% -$11.1K 0.6% 43
2019
Q3
$3.04M Sell
36,364
-123
-0.3% -$10.5K 0.64% 43
2019
Q2
$3.07M Sell
36,487
-62
-0.2% -$4.88K 0.69% 41
2019
Q1
$2.92M Sell
36,549
-697
-2% -$51.9K 0.69% 43
2018
Q4
$2.69M Sell
37,246
-1,526
-4% -$107K 0.68% 42
2018
Q3
$2.84M Sell
38,772
-7,131
-16% -$468K 0.69% 42
2018
Q2
$2.8M Sell
45,903
-7,903
-15% -$479K 0.74% 44
2018
Q1
$3.22M Buy
53,806
+3,660
+7% +$221K 0.89% 40
2017
Q4
$2.86M Sell
50,146
-2,940
-6% -$163K 0.85% 42
2017
Q3
$2.83M Sell
53,086
-1,392
-3% -$69.8K 0.91% 39
2017
Q2
$2.65M Sell
54,478
-2,681
-5% -$121K 0.92% 37
2017
Q1
$2.54M Sell
57,159
-5,706
-9% -$247K 0.96% 36
2016
Q4
$2.42M Buy
62,865
+10,419
+20% +$413K 0.95% 38
2016
Q3
$2.22M Sell
52,446
-416
-0.8% -$17.8K 0.98% 41
2016
Q2
$2.08M Buy
52,862
+671
+1% +$26.7K 0.94% 42
2016
Q1
$2.18M Buy
52,191
+1,964
+4% +$77.8K 1.06% 37
2015
Q4
$2.26M Buy
50,227
+108
+0.2% +$4.77K 1.18% 31
2015
Q3
$2.02M Buy
50,119
+745
+2% +$35.1K 1.28% 32
2015
Q2
$2.42M Buy
49,374
+562
+1% +$27K 1.55% 28
2015
Q1
$2.26M Sell
48,812
-271
-0.6% -$12.4K 1.53% 27
2014
Q4
$2.21M Buy
+49,083
New +$2.14M 1.54% 25

Other funds holding ABT

Blue Chip Partners's ABT Position: Q1 2026 in Review

Blue Chip Partners increased its Abbott (ABT) stake by 1.1% in Q1 2026, buying an estimated $258K and bringing the position to 208,691 shares worth $21.4M. The position accounts for 1.54% of the portfolio, ranked #27.

Blue Chip Partners first reported a position in ABT in Q4 2014 and has held it in 46 quarters since. The position peaked at $27M in Q3 2025. 3,086 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

  • Blue Chip Partners held 208,691 shares of Abbott worth $21.4M as of Q1 2026.
  • Blue Chip Partners bought 2,287 Abbott shares in Q1 2026, an estimated $258K.
  • Abbott made up 1.54% of Blue Chip Partners's portfolio in Q1 2026, its #27 holding.
  • Blue Chip Partners first reported a position in Abbott in Q4 2014 and has held it in 46 quarters since.
  • Blue Chip Partners's Abbott position peaked at $27M in Q3 2025.
  • 3,086 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on Blue Chip Partners's 13F filing for Q1 2026, filed 15 May 2026.